Exact Mass: 279.0022
Exact Mass Matches: 279.0022
Found 141 metabolites which its exact mass value is equals to given mass value 279.0022,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
7-Hydroxyticlopidine
7-Hydroxyticlopidine is a metabolite of Ticlopidine. 7-Hydroxyticlopidine belongs to the family of Thienopyridines. These are heterocyclic compounds containing a thiophene ring fused to a pyridine ring.
2-Oxoticlopidine
2-Oxoticlopidine is only found in individuals that have used or taken Ticlopidine. 2-Oxoticlopidine is a metabolite of Ticlopidine. 2-oxoticlopidine belongs to the family of Thienopyridines. These are heterocyclic compounds containing a thiophene ring fused to a pyridine ring.
Ticlopidine S-oxide
Ticlopidine S-oxide is only found in individuals that have used or taken Ticlopidine. Ticlopidine S-oxide is a metabolite of Ticlopidine. Ticlopidine s-oxide belongs to the family of Thienopyridines. These are heterocyclic compounds containing a thiophene ring fused to a pyridine ring.
Ticlopidine N-oxide
Ticlopidine N-oxide is a metabolite of ticlopidine. Ticlopidine (trade name Ticlid) is an antiplatelet drug in the thienopyridine family. Like clopidogrel, it is an adenosine diphosphate (ADP) receptor inhibitor. It is used in patients in whom aspirin is not tolerated, or in whom dual antiplatelet therapy is desirable. (Wikipedia)
2-(2,4-Dichloro-phenoxy)-N-(2-mercapto-ethyl)-acetamide
Fasentin
Fasentin, a potent glucose uptake inhibitor, inhibits GLUT-1/GLUT-4 transporters. Fasentin preferentially inhibits GLUT4 (IC50=68 μM) over GLUT1. Fasentin is a death receptor stimuli (FAS) sensitizer and sensitizes cells to FAS-induced cell death. Fasentin is also a tumor necrosis factor (TNF) apoptosis-inducing ligand sensitizer. Fasentin blocks glucose uptake in cancer cell lines and has anti-angiogenic activity[1][2][3].
2-Chloro-7-ethyl-6,8-dihydroxy-9H-pyrrolo[2,1-b][1,3]benzoxazine-9-one
tert-Butyl (3-bromo-1,2,4-thiadiazol-5-yl)carbamate
3-chloro-5-(2-chloro-5-hydroxyphenoxy)benzonitrile
sodium [3-(5-chloro-2-methoxyphenyl)-1-methyl-2-triazeno]acetate
(2-amino-5-chlorophenyl)(2-fluoro-6-Methoxyphenyl)Methanone
2-(5-benzylidene-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl)acetic acid
6-BROMO-2-METHYL-QUINOLINE-4-CARBOXYLIC ACID METHYL ESTER
2-Propenoic acid, 2-cyano-3-(4-bromophenyl)-, ethyl ester
2-BROMO-1-(5-METHYL-3-PHENYLISOXAZOL-4-YL)ETHAN-1-ONE
3-(4-FLUOROPHENYL)-3-(2,2,2-TRIFLUOROACETAMIDO)PROPANOIC ACID
6-Benzyl-2,4-dichloro-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidine
2-Bromomethylmorpholine-4-carboxylic acid tert-butyl ester
2-(2,3-DIHYDRO-1-BENZOFURAN-5-YL)-4-METHYLTHIAZOLE-5-CARBONYLCHLORIDE
1-(3-Bromophenyl)-5-methyl-1H-pyrazole-3-carboxamide
2-(6-amino-1,3-benzothiazol-2-yl)-4,5-dihydro-1,3-thiazole-4-carboxylic acid
dimethylammonium 2-(2,4-dichlorophenoxy)propionate
(2S)-2-amino-3-(4-bromophenyl)propanoic acid,hydrochloride
TPCA-1
D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors
4,7-Dichloro-8-methyl-2-(trifluoromethyl)quinoline
(R)-tert-Butyl 2-(bromomethyl)morpholine-4-carboxylate
(S)-tert-Butyl 2-(bromomethyl)morpholine-4-carboxylate
4-Chloro-8-(methylsulfanyl)-6-nitro-3-quinolinecarbonitrile
2-[(5-AMINO-1,3,4-THIADIAZOL-2-YL)THIO]-5-NITROBENZONITRILE
(4-carbamoyl-3-hydroxy-isothiazol-5-yl)-carbamic acid phenyl ester
6-bromo-2-(furan-2-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-amine
methyl 2-amino-2-(4-bromophenyl)acetate,hydrochloride
1-(3-BROMOPROPYL)-2,2,5,5-TETRAMETHYL-1-AZA-2,5-DISILACYCLOPENTANE
6-Bromo-2-[(2R)-2-pyrrolidinylmethyl]-1H-pyrrolo[2,3-b]pyridine
6-Bromo-2-[(2S)-2-pyrrolidinylmethyl]-1H-pyrrolo[2,3-b]pyridine
5-Bromo-2-[(2R)-2-pyrrolidinylmethyl]-1H-pyrrolo[2,3-b]pyridine
4-(4-fluorophenyl)sulfonylpiperidine,hydrochloride
4-anilino-6-chloro-2-methylsulfanylpyrimidine-5-carbaldehyde
ETHYL 8-CHLORO[1,3]DIOXOLO[4,5-G]QUINOLINE-7-CARBOXYLATE
7-BROMO-1,2,3,4-TETRAHYDRO-3-(TRIFLUOROMETHYL)-ISOQUINOLINE
5-(4-BROMO-PHENYL)-2-ISOPROPYL-2H-PYRAZOL-3-YLAMINE
2-(4-METHOXYBENZOYL)-3,3-DI(METHYLTHIO)ACRYLONITRILE
7-Bromo-5-fluoro-2-methyl-1,2,3,4-tetrahydro-isoquinoline hydrochloride
N-[2-chloro-5-(trifluoromethyl)phenyl]imidodicarbonimidic diamide
2-(2,4-Dichloro-phenoxy)-N-(2-mercapto-ethyl)-acetamide
5-[(2-Chlorophenyl)methyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-7-ol
N-[5-(methylthio)-1,3,4-thiadiazol-2-yl]-3-phenylpropanamide
(4S)-2-(6-hydroxy-1,3-benzothiazol-2-yl)-4,5-dihydro-1,3-thiazole-4-carboxylate
(4R)-2-(6-hydroxy-1,3-benzothiazol-2-yl)-4,5-dihydro-1,3-thiazole-4-carboxylate
N-[5-(ethylthio)-1,3,4-thiadiazol-2-yl]-4-methylbenzamide
2-[(3-Methoxyphenyl)-oxomethyl]-3,3-bis(methylthio)-2-propenenitrile
4-amino-3-methyl-N-(phenylmethyl)-2-sulfanylidene-5-thiazolecarboxamide
O3-(3-chlorobenzoyl)-5-methylisoxazole-3-carbohydroximamide
2-(2-Chlorophenyl)-5-fluoro-1,2-benzothiazol-3-one
5-(4-Hydroxy-3-nitrobenzylidene)-3-methyl-2-thioxo-4-imidazolidinone
(5Z)-5-(1-naphthylmethylene)[1,3]thiazolo[3,2-b][1,2,4]triazol-6(5H)-one
3-Chloro-4-[(2-fluorophenyl)methoxy]benzaldehyde oxime
2-Chloro-4-quinolinecarboxylic acid trimethylsilyl ester
ent-Photinus luciferin(1-)
A monocarboxylic acid anion that is the conjugate base of ent-Photinus luciferin, obtained by deprotonation of the carboxy group; major species at pH 7.3.
7-Hydroxyticlopidine
A thienopyridine that is ticlopidine which carries a hydroxy group at position 7. It is a metabolite of the antiplatelet drug, ticlopidine.
6-bromoconicamin
A bromoindole that is 1H-indole substituted by 2-(trimethylazaniumyl)ethenyl and bromo groups at positions 3 and 6, respectively. It is isolated from the marine sponge Geodia barretti.
